December 4, 2008 - Medtronic this week announced FDA approval of the Medtronic Sprint Quattro Secure S single coil defibrillation lead for use with implantable defibrillators in patients at risk for dangerous tachyarrhythmias and sudden cardiac arrest.
This new defibrillation lead is an addition to the Sprint Quattro family. The company said it provides an option for physicians who prefer a specific type of lead for patients with unique anatomies and is designed to help reduce tip pressure. The U.S. approval and market release of this single coil option follows its recent European approval and launch.
The Medtronic Sprint Quattro Secure S lead is designed with an 8.6 French diameter lead body (about 2.8mm in diameter). A thin wire inserted into the chambers of the heart through blood vessels, the lead is compatible with any Medtronic implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D), which are stopwatch-sized devices that administer electrical shocks or painless pacing therapy to stop dangerous ventricular arrhythmias.
“I prefer a single coil lead for my patients and am looking forward to having this new option available,” said Michael Lincoln, M.D., with Holy Cross Hospital in Silver Spring and NIH Heart Center at Suburban Hospital in Bethesda, MD. “Based on my own clinical experience and the breadth of long-term clinical performance data, I believe the Sprint Quattro family of defibrillation leads is highly reliable.”
For more information: www.medtronic.com